[
  {
    "ts": null,
    "headline": "Amgen Looks to Take Share of Booming Obesity Space: Will It Succeed?",
    "summary": "Amgen aims to challenge obesity drug leaders with MariTide, a potential monthly treatment now in late-stage trials.",
    "url": "https://finnhub.io/api/news?id=773e8df99e9f10d590e3ccd24d0d5cac94d2f98a2363ec640dd5a3421d8881c0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751033400,
      "headline": "Amgen Looks to Take Share of Booming Obesity Space: Will It Succeed?",
      "id": 135591900,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen aims to challenge obesity drug leaders with MariTide, a potential monthly treatment now in late-stage trials.",
      "url": "https://finnhub.io/api/news?id=773e8df99e9f10d590e3ccd24d0d5cac94d2f98a2363ec640dd5a3421d8881c0"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why Amgen (AMGN) is a Strong Growth Stock",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finnhub.io/api/news?id=bd7e16697d0fba576b0d03b84e2bcc508172181a3d444c51b6b805ce82d2ce46",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751031908,
      "headline": "Here's Why Amgen (AMGN) is a Strong Growth Stock",
      "id": 135597474,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=bd7e16697d0fba576b0d03b84e2bcc508172181a3d444c51b6b805ce82d2ce46"
    }
  },
  {
    "ts": null,
    "headline": "Cancer Vaccine (Preventative, Therapeutic) Market Research 2025 with Analyst Recommendations-Leveraging AI and Bioinformatics for Precision Development / Pursue Fast-Track and Orphan Drug Designations",
    "summary": "Explore the Global Cancer Vaccine Market's growth from $12.16 billion in 2024 to an expected $20.88 billion by 2031. Driven by innovations in immuno-oncology, the market is dominated by preventative and recombinant vaccines. Key players include Merck, Amgen, and Moderna. Asia Pacific sees fastest growth.Dublin, June 27, 2025 (GLOBE NEWSWIRE) -- The \"Cancer Vaccine Market (2025 Edition): Analysis By Type (Preventative, Therapeutic), By Technology Type, By Region, By Country: Market Insights and F",
    "url": "https://finnhub.io/api/news?id=501681acb583442180947cf8962a4d2e2b51d6cef9fad0b9a970248afed5f4fd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751031300,
      "headline": "Cancer Vaccine (Preventative, Therapeutic) Market Research 2025 with Analyst Recommendations-Leveraging AI and Bioinformatics for Precision Development / Pursue Fast-Track and Orphan Drug Designations",
      "id": 135590979,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Explore the Global Cancer Vaccine Market's growth from $12.16 billion in 2024 to an expected $20.88 billion by 2031. Driven by innovations in immuno-oncology, the market is dominated by preventative and recombinant vaccines. Key players include Merck, Amgen, and Moderna. Asia Pacific sees fastest growth.Dublin, June 27, 2025 (GLOBE NEWSWIRE) -- The \"Cancer Vaccine Market (2025 Edition): Analysis By Type (Preventative, Therapeutic), By Technology Type, By Region, By Country: Market Insights and F",
      "url": "https://finnhub.io/api/news?id=501681acb583442180947cf8962a4d2e2b51d6cef9fad0b9a970248afed5f4fd"
    }
  }
]